$100,000 supporting cholangiocarcinoma research at the Bardeesy Laboratory at the Massachusetts General Hospital Cancer Center
• This grant marks the fourth year of TargetCancer's ongoing commitment to develop a comprehensive cholangiocarcinoma research program, and also includes continued funding for the TargetCancer Cholangiocarcinoma Cell Line Bank.
Learn more about TargetCancer’s cholangiocarcinoma research support here.
$50,000 supporting a new esophageal cancer collaboration incorporating genomics and immunotherapy at the Dana-Farber Cancer Institute
• TargetCancer initiated this creative collaboration between Adam Bass, MD, and Michael Goldberg, Ph.D., uniting experts in cancer genomics and cancer immunology to identify potential combination genetic and immunotherapeutic drug therapies for esophageal cancer.
Learn more about this collaboration here.
Both of these grants were funded free of overhead and indirect costs – 100% of the funding is being directed to the researchers.
The TargetCancer Story
TargetCancer premiered a new short film about its history and work at the 4th Annual TargetCancer Gala. You can watch the video below.
|Join Our Mailing List|